Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
NBRV | Nabriva Therapeutics plc | CORRIGAN MARK | Director | Aug 02, 2022 | Sale | $0.19 | 10,297 | 1,956 | 7,203 | Aug 04, 2022, 06:19 PM | |
CBST | CUBIST PHARMACEUTICALS INC | CORRIGAN MARK | Director | Jan 21, 2015 | Option Exercise | $102.00 | 7,501 | 765,102 | 0 | Jan 21, 2015, 05:08 PM | |
EPRS | EPIRUS Biopharmaceuticals, Inc. | CORRIGAN MARK | Director | Jul 15, 2014 | Option Exercise | $11.80 | 14,597 | 172,245 | 21,859 | Jul 17, 2014, 09:18 PM | |
CBST | CUBIST PHARMACEUTICALS INC | CORRIGAN MARK | Director | Feb 27, 2014 | Option Exercise | $49.11 | 10,000 | 491,100 | 10,498 | Feb 28, 2014, 02:06 PM | |
ZLCS | Zalicus Inc. | CORRIGAN MARK | President & CEO | Jan 15, 2014 | Option Exercise | $1.66 | 18,079 | 30,011 | 114,567 | Jan 17, 2014, 04:04 PM | |
ZLCS | Zalicus Inc. | CORRIGAN MARK | President & CEO | Jan 03, 2014 | Option Exercise | $1.22 | 8,035 | 9,803 | 132,646 | Jan 07, 2014, 04:16 PM | |
CBST | CUBIST PHARMACEUTICALS INC | CORRIGAN MARK | Director | May 24, 2013 | Option Exercise | $36.41 | 28,000 | 1,019,542 | 17,156 | May 29, 2013, 09:00 AM | |
ZLCS | Zalicus Inc. | CORRIGAN MARK | President & CEO | Jan 15, 2013 | Sale | $0.77 | 112,850 | 86,894 | 844,090 | Jan 17, 2013, 04:10 PM | |
CBST | CUBIST PHARMACEUTICALS INC | CORRIGAN MARK | Director | Jul 24, 2012 | Sale | $29.39 | 20,000 | 587,875 | 13,156 | Jul 26, 2012, 04:11 PM | |
ZLCS | Zalicus Inc. | CORRIGAN MARK | President & CEO | Jan 17, 2012 | Sale | $1.14 | 68,105 | 77,640 | 706,940 | Jan 19, 2012, 04:14 PM | |
ZLCS | Zalicus Inc. | CORRIGAN MARK | President & CEO | Jan 18, 2011 | Sale | $2.18 | 62,160 | 135,509 | 775,045 | Jan 20, 2011, 08:33 AM |